VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ACUAcme United Corporation
$45.38$173M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

ACU logoAcme United Corporation(ACU)Earnings, Financials & Key Ratios

ACU•AMEX
18.2× P/E·Price updated Jun 19, 2026
SectorConsumer DefensiveIndustryHousehold ProductsSub-IndustryConsumer Health and Wellness Products
AboutAcme United Corporation supplies first aid and safety, cutting, sharpening, and measuring products to the school, home, office, hardware, sporting goods, and industrial markets in the United States, Canada, Europe, and internationally. The company offers scissors, shears, knives, rulers, pencil sharpeners, paper trimmers, safety cutters, lettering products, glue guns, and other craft products under the Westcott brand name; and cutting tools under the Clauss brand. It also provides fixed blades, folding knives, sight cutting tools, and tactical tools under the Camillus brand; fishing tools and knives, as well as cut and puncture resistant gloves, telescopic landing nets, net containment systems, and tools and fishing gaffs under the Cuda brand; and sharpening tools under the DMT brand. In addition, the company offers first aid kit and safety solutions under the First Aid Only brand; portable eyewash solution and over-the-counter medication, including active ingredients aspirin, acetaminophen, and ibuprofen under the PhysiciansCare brand; bodily fluid and spill clean-up solution under the Spill Magic brand; various first aid kit, refill, and safety supplies, including CPR kits, burn kits, and automotive and emergency first aid kits under the First Aid Central; and alcohol prep pads, alcohol wipes, benzalkonium chloride wipes, various antiseptic wipes, castile soaps, and lens cleaning wipes under the Med-Nap brand. It sells its products directly and through its independent manufacturer representatives to wholesale, contract, and retail stationery distributors; office supply super stores; school supply distributors; industrial distributors; wholesale florists; mass market and e-commerce retailers; and hardware chains, as well as sells a selection of products through its websites. The company was formerly known as Acme Shear Company and changed its name to Acme United Corporation in 1971. Acme United Corporation was founded in 1867 and is based in Shelton, Connecticut.Show more
  • Revenue$197M+1.1%
  • EBITDA$21M+4.3%
  • Net Income$10M+1.6%
  • EPS (Diluted)2.49+1.6%
  • Gross Margin39.39%+0.3%
  • EBITDA Margin10.72%+3.2%
  • Operating Margin7.49%+3.0%
  • Net Margin5.18%+0.6%
  • ROE9.07%-7.3%

ACU Key Insights

Acme United Corporation (ACU) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong Piotroski F-Score: 7/9
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Trading near 52-week high
  • ✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when ACU posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ACU Price & Volume

Acme United Corporation (ACU) stock price & volume — 10-year historical chart

Loading chart...

ACU Growth Metrics

Acme United Corporation (ACU) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years5.99%
5 Years3.69%
3 Years0.44%
TTM-22.95%

Profit CAGR

10 Years7.83%
5 Years4.69%
3 Years49.72%
TTM-15.02%

EPS CAGR

10 Years6.72%
5 Years1.51%
3 Years44.81%
TTM-5.31%

Return on Capital

10 Years9.45%
5 Years9.29%
3 Years10.28%
Last Year10.12%

ACU Recent Earnings

Acme United Corporation (ACU) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
Apr 23, 2026
Metric
Actual
Est
EPS
$0.24-56.4%
$0.55
Rev
$52M+4.6%
$50M
Q1 2026
Feb 26, 2026
Metric
Actual
Est
EPS
$0.46+0.0%
$0.46
Rev
$48M-0.5%
$48M
Q4 2025
Oct 21, 2025
Metric
Actual
Est
EPS
$0.46-27.0%
$0.63
Rev
$49M+3.8%
$47M
Q3 2025
Jul 23, 2025
Metric
Actual
Est
EPS
$1.16+132.0%
$0.50
Rev
$54M+5.8%
$51M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 23, 2026
$0.24vs $0.55-56.4%
$52Mvs $50M+4.6%
Q1 2026Feb 26, 2026
$0.46vs $0.46+0.0%
$48Mvs $48M-0.5%
Q4 2025Oct 21, 2025
$0.46vs $0.63-27.0%
$49Mvs $47M+3.8%
Q3 2025Jul 23, 2025
$1.16vs $0.50+132.0%
$54Mvs $51M+5.8%
Based on last 12 quarters of dataView full earnings history →

ACU Peer Comparison

Acme United Corporation (ACU) competitors in Consumer Health and Wellness Products — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
LCUT logoLCUTLifetime Brands, Inc.Direct Competitor192.9M8.44-6.81-5.13%-4.22%-14.29%1.20
LESL logoLESLLeslie's, Inc.Direct Competitor85.83M9.17-0.36-6.63%-22.64%
SMID logoSMIDSmith-Midland CorporationDirect Competitor161.84M30.5121.0431.77%13.25%22.58%0.12
ACCO logoACCOACCO Brands CorporationDirect Competitor359.81M3.908.86-8.49%4.76%11.26%1.39
FONR logoFONRFONAR CorporationDirect Competitor117.84M19.0915.521.43%6.35%4.12%0.24
SWK logoSWKStanley Black & Decker, Inc.Product Competitor13.49B86.7532.74-1.53%2.44%4.12%0.65
KMT logoKMTKennametal Inc.Product Competitor2.77B36.3230.27-3.91%6.41%10.14%0.49
SPXC logoSPXCSPX Technologies, Inc.Product Competitor12.19B242.9748.0214.17%10.8%12.37%0.22

Compare ACU vs Peers

Acme United Corporation (ACU) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs LCUT

Most directly comparable listed peer for ACU.

Scale Benchmark

vs MMM

Larger-name benchmark to compare ACU against a more recognizable public peer.

Peer Set

Compare Top 5

vs LCUT, LESL, SMID, ACCO

ACU Income Statement

Acme United Corporation (ACU) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
130.55M137.32M142.46M164M182.09M193.96M191.5M194.49M196.54M150.64M
Revenue Growth %
4.8%5.19%3.74%15.12%11.03%6.52%-1.27%1.56%1.06%-22.95%
Cost of Goods Sold
82.65M86.67M90.46M104.41M117.29M130.4M119.29M118.14M119.13M91.12M
COGS % of Revenue
63.31%63.12%63.5%63.66%64.41%67.23%62.29%60.74%60.61%-
Gross Profit
47.9M▲ 0%
50.65M▲ 5.7%
52M▲ 2.7%
59.59M▲ 14.6%
64.8M▲ 8.7%
63.56M▼ 1.9%
72.21M▲ 13.6%
76.35M▲ 5.7%
77.41M▲ 1.4%
59.51M▲ 0%
Gross Margin %
36.69%36.88%36.5%36.34%35.59%32.77%37.71%39.26%39.39%39.51%
Gross Profit Growth %
5.15%5.74%2.67%14.6%8.74%-1.92%13.61%5.73%1.39%-
Operating Expenses
40.1M43.19M43.57M48.18M52.03M57.28M59.02M62.21M62.69M47.21M
OpEx % of Revenue
30.72%31.45%30.59%29.38%28.57%29.53%30.82%31.99%31.89%-
Selling, General & Admin
40.1M43.19M42.98M47.93M52.03M57.28M59.02M62.21M62.69M30.74M
SG&A % of Revenue
30.72%31.45%30.17%29.23%28.57%29.53%30.82%31.99%31.89%-
Research & Development
752K734K596K251K000000
R&D % of Revenue
0.58%0.53%0.42%0.15%------
Other Operating Expenses
25K-68K00-196K-246K0-11801.3M
Operating Income
7.88M▲ 0%
7.46M▼ 5.4%
8.43M▲ 13.0%
11.41M▲ 35.4%
12.77M▲ 11.9%
6.27M▼ 50.9%
13.19M▲ 110.2%
14.14M▲ 7.2%
14.72M▲ 4.1%
12.8M▲ 0%
Operating Margin %
6.04%5.43%5.92%6.96%7.01%3.23%6.89%7.27%7.49%8.5%
Operating Income Growth %
-6.62%-5.4%13.04%35.39%11.89%-50.87%110.23%7.21%4.14%-
EBITDA
10.78M10.69M11.88M15.25M16.98M10.81M18.26M20.21M21.07M19.39M
EBITDA Margin %
8.26%7.78%8.34%9.3%9.32%5.57%9.53%10.39%10.72%12.87%
EBITDA Growth %
-0.79%-0.85%11.18%28.36%11.32%-36.33%68.91%10.7%4.27%-3.6%
D&A (Non-Cash Add-back)
2.89M3.23M3.45M3.84M4.21M4.54M5.07M6.07M6.35M4.85M
EBIT
7.85M7.42M8.37M10.77M16.1M6.06M25.83M14.38M15.22M14.67M
Net Interest Income
-1.33M-1.86M-1.79M-919.71K-908.22K-2.36M-2.98M-1.94M-1.56M-1.22M
Interest Income
29K33K40K24.65K14K32K119.32K141.32K123K64.03K
Interest Expense
1.36M1.89M1.83M944.36K922K2.4M3.1M2.08M1.68M1.29M
Other Income/Expense
-1.39M-1.93M-1.89M-1.59M2.4M-2.61M9.55M-1.85M-1.61M-1.8M
Pretax Income
6.49M▲ 0%
5.53M▼ 14.8%
6.54M▲ 18.3%
9.83M▲ 50.2%
15.18M▲ 54.4%
3.66M▼ 75.9%
22.73M▲ 520.7%
12.29M▼ 45.9%
13.12M▲ 6.7%
11M▲ 0%
Pretax Margin %
4.97%4.03%4.59%5.99%8.33%1.89%11.87%6.32%6.67%7.3%
Income Tax
2.44M933K1.03M1.73M1.52M628K4.94M2.27M2.93M2.47M
Effective Tax Rate %
37.59%16.87%15.73%17.58%10.01%17.14%21.74%18.47%22.36%22.44%
Net Income
4.05M▲ 0%
4.6M▲ 13.5%
5.51M▲ 19.9%
8.1M▲ 46.9%
13.66M▲ 68.6%
3.03M▼ 77.8%
17.79M▲ 486.3%
10.02M▼ 43.7%
10.19M▲ 1.6%
8.53M▲ 0%
Net Margin %
3.1%3.35%3.87%4.94%7.5%1.56%9.29%5.15%5.18%5.66%
Net Income Growth %
-30.75%13.47%19.91%46.89%68.61%-77.78%486.31%-43.67%1.62%-15.02%
Net Income (Continuing)
4.05M4.6M5.51M8.1M13.66M3.03M17.79M10.02M10.19M8.53M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
1.09▲ 0%
1.30▲ 19.3%
1.60▲ 23.1%
2.31▲ 44.4%
3.45▲ 49.4%
0.82▼ 76.2%
4.86▲ 492.7%
2.45▼ 49.6%
2.49▲ 1.6%
2.05▲ 0%
EPS Growth %
-33.54%19.27%23.08%44.38%49.35%-76.23%492.68%-49.59%1.63%-5.31%
EPS (Basic)
1.211.361.652.423.930.864.982.712.69-
Diluted Shares Outstanding
3.73M3.54M3.45M3.51M3.96M3.72M3.66M4.1M4.09M4.16M
Basic Shares Outstanding
3.36M3.37M3.35M3.34M3.47M3.53M3.66M3.7M3.79M3.81M
Dividend Payout Ratio
34.76%32.29%29.18%19.81%13.13%62.72%11.2%22.17%23.01%-

ACU Balance Sheet

Acme United Corporation (ACU) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
77.82M72.99M73.15M83.69M95.25M105.6M92.02M95.46M96.2M105.61K
Cash & Short-Term Investments
9.34M4.41M6.82M4.17M4.84M6.1M4.8M6.4M3.6K4.2K
Cash Only
9.34M4.41M6.82M4.17M4.84M6.1M4.8M6.4M3.6K4.2K
Short-Term Investments
0000000000
Accounts Receivable
26.01M25.1M25.48M27.17M34.22M32.6M26.23M28.24M29.1K33.51K
Days Sales Outstanding
72.7366.7265.360.4868.661.355052.990.0540.14
Inventory
40.09M41.33M39.26M50.7M53.55M63.33M55.47M56.25M59.85K63.39K
Days Inventory Outstanding
177.03174.06158.42177.26166.66177.25169.72173.80.18117.76
Other Current Assets
00000750K750K096.1M4.52K
Total Non-Current Assets
36.91M36.49M37.6M46.18M49.19M58.78M57.22M66.71M78.41M89.63K
Property, Plant & Equipment
13.73M14.54M17.02M22.66M27.16M29.05M30.03M36.48M45.42K45.7K
Fixed Asset Turnover
9.51x9.44x8.37x7.24x6.70x6.68x6.38x5.33x4327.02x6.96x
Goodwill
4.7M4.7M4.7M4.8M4.8M8.19M8.19M9.91M9.91K9.91K
Intangible Assets
17.88M17.04M15.79M18.72M17.23M20.79M19M20.32M19.47K34.02K
Long-Term Investments
0000000000
Other Non-Current Assets
96K88.9K88.83K00750K0074.73M0
Total Assets
114.73M▲ 0%
109.48M▼ 4.6%
110.75M▲ 1.2%
129.87M▲ 17.3%
144.44M▲ 11.2%
164.38M▲ 13.8%
149.24M▼ 9.2%
162.17M▲ 8.7%
174.6M▲ 7.7%
195.24K▲ 0%
Asset Turnover
1.14x1.25x1.29x1.26x1.26x1.18x1.28x1.20x1.13x1.75x
Asset Growth %
24.62%-4.58%1.16%17.26%11.22%13.8%-9.21%8.66%7.67%-196.74%
Total Current Liabilities
16.78M13.36M16.58M20.2M20.28M22.13M26.01M22.87M22.87M23.11K
Accounts Payable
11.15M7.98M6.69M7.6M8.98M10.51M12.1M9M8.07K7.65K
Days Payables Outstanding
49.2433.6227.0126.5727.9429.4337.0327.820.0216.71
Short-Term Debt
266.67K266.67K00000436.95K01.37K
Deferred Revenue (Current)
0000000000
Other Current Liabilities
00266.67K3.34M1.97M404.59K419.31K021.42M14.08K
Current Ratio
4.64x5.46x4.41x4.14x4.70x4.77x3.54x4.17x4.21x4.57x
Quick Ratio
2.25x2.37x2.04x1.63x2.06x1.91x1.41x1.71x4.20x1.83x
Cash Conversion Cycle
200.51207.16196.71211.16207.32209.17182.7198.970.21141.2
Total Non-Current Liabilities
48.01M43.78M38.46M46.95M47.08M63.22M25.33M32.32M34.12M55.41K
Long-Term Debt
47.16M43.73M36.42M45.19M44.12M60.61M23.39M27.47M21.29M38.21K
Capital Lease Obligations
001.96M1.65M2.36M1.68M1.03M3.37M5.53M22.79M
Deferred Tax Liabilities
0049.28K110.22K599.28K305.29K899.34K1.46M7.29M10.22M
Other Non-Current Liabilities
847.38K53.13K32.3K00622.44K16.27K13.36K13.97K17.2K
Total Liabilities
64.79M57.15M55.04M67.15M67.36M85.35M51.34M55.19M56.99M78.52K
Total Debt
47.43M43.99M39.43M47.71M47.48M63.42M25.51M32.84M28.72M39.58K
Net Debt
38.09M39.59M32.6M43.55M42.64M57.32M20.72M26.44M28.71M35.38K
Debt / Equity
0.95x0.84x0.71x0.76x0.62x0.80x0.26x0.31x0.24x0.34x
Debt / EBITDA
4.40x4.12x3.32x3.13x2.80x5.87x1.40x1.63x1.36x0.00x
Net Debt / EBITDA
3.53x3.70x2.74x2.86x2.51x5.30x1.13x1.31x1.36x0.00x
Interest Coverage
5.78x3.93x4.58x11.41x17.46x2.53x8.34x6.90x9.05x11.39x
Total Equity
49.94M▲ 0%
52.33M▲ 4.8%
55.7M▲ 6.4%
62.72M▲ 12.6%
77.08M▲ 22.9%
79.03M▲ 2.5%
97.9M▲ 23.9%
106.98M▲ 9.3%
117.61M▲ 9.9%
116.73K▲ 0%
Equity Growth %
8.28%4.79%6.44%12.59%22.91%2.53%23.88%9.28%9.94%-71.68%
Book Value per Share
13.4114.7716.1317.8719.4921.2526.7726.1028.780.03
Total Shareholders' Equity
49.94M52.33M55.7M62.72M77.08M79.03M97.9M106.98M117.61M116.73K
Common Stock
12.09M12.09M12.09M12.1M12.65M12.7M12.97M13.25M13.38M0
Retained Earnings
44.47M47.55M51.57M58.03M69.87M70.97M86.72M94.5M102.29M0
Treasury Stock
-13.87M-14.24M-14.24M-14.52M-16M-16M-16M-16M-16M0
Accumulated OCI
-1.63M-2.06M-1.99M-825.97K-1.38M-2.09M-1.71M-2.75M-1.57M0
Minority Interest
0000000000

ACU Cash Flow Statement

Acme United Corporation (ACU) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
4.81M4.48M14.7M5.72M5.14M2.89M28.9M11.98M18.23M21.57M
Operating CF Margin %
3.69%3.26%10.32%3.49%2.82%1.49%15.09%6.16%9.28%-
Operating CF Growth %
-45.68%-6.98%228.52%-61.09%-10.15%-43.75%899.38%-58.56%52.23%99.56%
Net Income
4.05M4.6M5.51M8.1M13.66M3.03M17.79M10.02M10.18B8.53M
Depreciation & Amortization
2.89M3.23M3.43M3.75M4.05M4.58M5.07M06.35B6.35B
Stock-Based Compensation
684.35K869.05K968.47K1.26M1.81M1.8M1.94M01.99B1.99B
Deferred Taxes
660.7K396.23K162.64K60.94K489.06K-294K594.06K02.22B2.22B
Other Non-Cash Items
9.82M11.17M309.35K1.39M-3.35M377.45K-9.45M9.24M-20.72B-20.73B
Working Capital Changes
-3.48M-4.62M4.32M-8.84M-11.51M-6.61M12.95M-7.28M-2.86M4.2M
Change in Receivables
-5.23M807.99K-784.56K-2.03M-7.23M1.84M6.33M-2.46M-592.82K1.91M
Change in Inventory
-1.85M-1.58M2.09M-10.05M-3.21M-9.61M3.65M-329.9K-3.07M-2.07M
Change in Payables
3.73M-3.07M-1.53M460.18K1.5M1.91M1.55M-2.98M-1.06M749.28K
Cash from Investing
-14.38M-3.23M-1.68M-13.95M-6.37M-14.23M7.43M-12.94M-12.3M-10.95M
Capital Expenditures
-7.15M-3.23M-1.68M-2.57M-6.37M-4.3M-4.67M-7.15M-10.65B-10.66B
CapEx % of Revenue
5.47%2.35%1.18%1.57%3.5%2.22%2.44%3.68%5419.66%7076%
Acquisitions
-7.23M00-11.38M0-9.62M12.4M-5.79M-1.65M-1.65M
Investments
----------
Other Investing
-11.23B-379.92K000-300K-301.74K010.64B10.65B
Cash from Financing
12.91M-6.05M-10.61M5.29M2.04M14.28M-38.44M2M-8.88M-10.57M
Debt Issued (Net)
14.49M-3.43M-7.31M8.77M2.56M16.45M-37.25M4.06M-6.2M-8.92M
Equity Issued (Net)
649.23K-365.15K0-228.23K1.62M84.72K1.45M1.62M697.53K697.53K
Dividends Paid
-1.41M-1.48M-1.61M-1.6M-1.79M-1.9M-1.99M-2.22M-2.34M-1.78M
Share Repurchases
0-365.15K0-286.99K-1.47M00000
Other Financing
-823.53K-768.08K-1.69M-1.64M-342.29K-351.62K-655.42K-1.46M-1.04M-572.89K
Net Change in Cash
3.43M▲ 0%
-4.93M▼ 243.8%
2.41M▲ 148.9%
-2.65M▼ 210.0%
675.97K▲ 125.5%
2.76M▲ 307.9%
-2.05M▼ 174.5%
852.74K▲ 141.5%
-2.8M▼ 428.7%
149.98K▲ 0%
Free Cash Flow
-2.34M▲ 0%
1.24M▲ 153.3%
13.02M▲ 946.5%
3.15M▼ 75.8%
-1.23M▼ 139.1%
-1.71M▼ 39.0%
23.92M▲ 1497.0%
4.83M▼ 79.8%
7.58M▲ 57.0%
12.27M▲ 0%
FCF Margin %
-1.79%0.91%9.14%1.92%-0.68%-0.88%12.49%2.48%3.86%8.14%
FCF Growth %
-133.28%153.28%946.47%-75.8%-139.09%-39%1497%-79.83%57%2.95%
FCF per Share
-0.630.353.770.90-0.31-0.466.541.181.852.95
FCF Conversion (FCF/Net Income)
1.19x0.97x2.67x0.71x0.38x0.95x1.62x1.19x1.79x1.44x
Interest Paid
1.26M1.86M1.86M930.36K908.78K2.12M3.18M1.9M1.57M1.2M
Taxes Paid
1.57M887.59K422.34K755.34K875K978.38K5.77M2.25M560.72K475.72K

ACU Key Ratios

Acme United Corporation (ACU) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
8.44%8.99%10.21%13.68%19.54%3.89%20.11%9.78%9.07%9.83%
Return on Invested Capital (ROIC)
7.34%6.22%7.02%8.8%8.48%3.67%7.76%8.42%7.9%8.81%
Gross Margin
36.69%36.88%36.5%36.34%35.59%32.77%37.71%39.26%39.39%39.51%
Net Margin
3.1%3.35%3.87%4.94%7.5%1.56%9.29%5.15%5.18%5.66%
Debt / Equity
0.95x0.84x0.71x0.76x0.62x0.80x0.26x0.31x0.24x0.34x
Interest Coverage
5.78x3.93x4.58x11.41x17.46x2.53x8.34x6.90x9.05x11.39x
FCF Conversion
1.19x0.97x2.67x0.71x0.38x0.95x1.62x1.19x1.79x1.44x
Revenue Growth
4.8%5.19%3.74%15.12%11.03%6.52%-1.27%1.56%1.06%-22.95%
Related:ACU Dividend History·ACU Revenue History·ACU Price History·ACU P/E History·ACU Financial Ratios·ACU Institutional Holders

ACU SEC Filings & Documents

Acme United Corporation (ACU) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 23, 2026·SEC

Material company update

Feb 26, 2026·SEC

Material company update

Jan 22, 2026·SEC

10-K Annual Reports

5
FY 2026

Mar 11, 2026·SEC

FY 2025

Mar 6, 2025·SEC

FY 2024

Mar 7, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 6, 2025·SEC

FY 2025

May 7, 2025·SEC

ACU Frequently Asked Questions

Acme United Corporation (ACU) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Acme United Corporation (ACU) reported $150.6M in revenue for fiscal year 2025. This represents a 217% increase from $47.5M in 1996.

Acme United Corporation (ACU) grew revenue by 1.1% over the past year. Growth has been modest.

Yes, Acme United Corporation (ACU) is profitable, generating $8.5M in net income for fiscal year 2025 (5.2% net margin).

Dividend & Returns

Yes, Acme United Corporation (ACU) pays a dividend with a yield of 1.26%. This makes it attractive for income-focused investors.

Acme United Corporation (ACU) has a return on equity (ROE) of 9.1%. This is below average, suggesting room for improvement.

Acme United Corporation (ACU) generated $12.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in ACU back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

How much would $100/month in ACU be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →